Trial intelligence / Profile preview

Effect of tranexamic acid on patients undergoing functional endoscopic sinus surgery (FESS)

IRCT20221204056707N1Phase 3Completed

Sponsor
Qazvin University of Medical Sciences
Start
Feb 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in rhinosinusitis, sponsored by Qazvin University of Medical Sciences. Started Feb 2024; status: completed.

02

Drugs

tranexamic acid
03

Conditions

rhinosinusitis

Beyond the preview

Go deeper on IRCT20221204056707N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221204056707N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call